Optimizing detection of clinically significant prostate cancer through nomograms incorporating mri, clinical features, and advanced serum biomarkers in biopsy naïve men.
Mohammad R SiddiquiEric V LiSai K S R KumarAnna BuszaJasmine S LinAshorne K MahenthiranJonathan A AguiarParth V ShahBrandon AnsbroJordan M RichSoliman A S MoatazMary-Kate KeeterQuan MaiXinlei MiJeffrey J TosoianEdward M SchaefferHiten D PatelAshley Evan RossPublished in: Prostate cancer and prostatic diseases (2023)
Here we developed nomograms combining serum testing and mpMRI to help clinicians risk stratify patients with elevated PSA of 2-20 ng/mL who are being considered for biopsy. Our nomograms are available at https://rossnm1.shinyapps.io/MynMRIskCalculator/ to aid with biopsy decisions.